Tag Cloud Results

Results found matching tag Sanofi

From the News
Wechsel in der Direktion von Sanofi zum 1. Dezember
Sanofi Announces New Long Term Objectives
Sanofi Aventis & Multicare Ink Strategic Agreement in the Philippines
Sanofi make generic of Pfizer's Lipitor
SkyePharma Announces Exclusive Development, License and Marketing Agreement for Flutiform with Sanofi
New Senior Executives appointed at Sanofi: Greg Irace, Senior Vice President, Global Services Anne Whitaker, ...
Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada*) in Multiple ...
Sanofi signs research pact with Rib-X Pharma
Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments ...
Sanofi Announces Positive Results from the “All to Target” Study Evaluating Two Lantus and Apidra ...
Sanofi Pasteur’s Typhoid Vaccine, Typhim Vi, Granted Prequalification by the World Health Organization
Sanofi Establishes a Global Agreement with Medco and UBC to Improve Quality of Patient Care through Real-World ...
Sanofi Enters into Research Collaboration with Biopharmaceutical Company Audion Therapeutics to Develop ...
Sanofi GetGoal Program on Lyxumia, as an Add-on to Basal Insulin
Sanofi Iniparib and Semuloparin Phase III Data Selected for Oral Presentation for Cancer and Best of ...
Sanofi Pasteur Launches Pentaxim, First 5-in-1 Combination Vaccine in China
FDA Licenses Sanofi Pasteur’s New Influenza Vaccine Delivered by Intradermal Microinjection
Sanofi Pasteur Enters into R&D Collaboration with Dyadic Netherlands and EnGen Bio
Sanofi-aventis and Medicines for Malaria Venture Join Forces to Develop Innovative Malaria Drugs
Sanofi-aventis and Regeneron Report Positive Phase III Results with ZALTRAP (aflibercept) in Second-line ...
Sanofi-Aventis Completes Acquisition of Genzyme Corporation
sanofi-aventis On The Starting Line at The 2011 Tour de Suisse With a Wild Card
Sanofi-aventis announces registration statement for CVR related to Genzyme acquisition declared effective
Sanofi-aventis strengthens commitment to ophthalmology through partnership with The Vision Institute
Merck and sanofi-aventis to maintain separate businesses in animal health
Sanofi-Aventis Recalls ActHIB vaccine
Sanofi-aventis appoints Dr. Richard Klausner as Chairman of the Strategic Development and Scientific ...
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) ...
Composition of the Board of Directors of sanofi-aventis
Sanofi-aventis signs New Agreement with the World Health Organization (WHO) to fight Neglected Tropical ...
Sanofi-aventis Extends Offer for all Outstanding Shares of Genzyme
Sanofi-Aventis: acquisition of BMP Sunstone acquisition
FDA Issues Sanofi-Aventis warning letters
Sanofi-aventis eyes OTC, branded generics in India
Sanofi Pasteur and International Vaccine Institute partner against dengue
Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right
Sanofi completes Genzyme review: report
Did monkey wrench or due diligence delay the Sanofi-Genzyme deal?
Diversification key to future growth at Sanofi
Sanofi, Genzyme takeover talks enter final stretch
Sanofi-aventis - Hospira now sees delayed cancer drug approval at quarter end
Zealand and Sanofi-Aventis achieve first Phase III success for Lixisenatide monotherapy
A.M. Vitals: Sanofi may pay $74 per share up front for Genzyme
Genzyme will allow Sanofi-aventis to conduct due diligence
UPDATE 1-Sanofi falls on cancer drug setback
Sanofi-aventis breast cancer drug fails in Phase III study
Sanofi-Aventis Generics Company Intelligence Report
Sanofi-aventis acquires exclusive license to Oxford Bio's therapeutic antibody for solid cancers